Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Cellectis S.A. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −10 vs. Q3 2022
- Shares held
- 8.73M
- −1.57M (−15.2%) vs. Q3 2022
- Total value
- $18.3M
- −$5.27M (−22.3%) vs. Q3 2022
- New holders
- 6
- 9 more added
- Sold out
- 16
- 12 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 65 | $0 | 0.00% | +9+16.1% | Added |
| Sofos Investments, Inc. | 2 | $2 | 0.00% | −6−75.0% | Reduced |
| FMR LLC | 9 | $19 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 10 | $21 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 28 | $59 | 0.00% | −622−95.7% | Reduced |
| Parkside Financial Bank & Trust | 147 | $309 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 166 | $349 | 0.00% | +166 | New |
| Citigroup Inc | 263 | $552 | 0.00% | +10+4.0% | Added |
| TD Waterhouse Canada Inc. | 360 | $806 | 0.00% | 00.0% | Unchanged |
| Money Concepts Capital Corp | 515 | $1.08K | 0.00% | +515 | New |
| JPMorgan Chase & Co | 1,598 | $3.00K | 0.00% | +248+18.4% | Added |
| Assetmark, Inc | 1,520 | $3.19K | 0.00% | +380+33.3% | Added |
| BlackRock Inc. | 2,755 | $5.79K | 0.00% | −278,946−99.0% | Reduced |
| National Bank of Canada | 3,600 | $7.45K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,447 | $11.4K | 0.00% | +1,540+39.4% | Added |
| Advisor Group Holdings, Inc. | 6,237 | $13.0K | 0.00% | −166−2.6% | Reduced |
| Bank of America Corp | 7,119 | $14.9K | 0.00% | −11,944−62.7% | Reduced |
| Geode Capital Management, LLC | 10,776 | $22.0K | 0.00% | 00.0% | Unchanged |
| Old Mission Capital LLC | 11,752 | $24.7K | 0.00% | +11,752 | New |
| Vontobel Holding Ltd. | 14,000 | $29.4K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 16,979 | $35.7K | 0.00% | −250−1.5% | Reduced |
| Goldman Sachs Group Inc | 18,208 | $38.2K | 0.00% | +18,208 | New |
| Ergoteles LLC | 19,365 | $40.7K | 0.00% | +19,365 | New |
| Tower Research Capital LLC (TRC) | 26,362 | $56.0K | 0.00% | +19,300+273.3% | Added |
| Envestnet Asset Management Inc | 57,447 | $120.6K | 0.00% | +11,928+26.2% | Added |
| Susquehanna International Group, LLP | 58,087 | $122.0K | 0.00% | +58,087 | New |
| Citadel Advisors LLC | 58,207 | $122.2K | 0.00% | +45,849+371.0% | Added |
| Morgan Stanley | 74,141 | $155.7K | 0.00% | −1,812−2.4% | Reduced |
| Oppenheimer & Co Inc | 75,052 | $157.6K | 0.00% | −16,911−18.4% | Reduced |
| KBC Group NV | 163,447 | $343.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 211,467 | $449.6K | 0.00% | −132,427−38.5% | Reduced |
| Macquarie Group Ltd | 226,875 | $476.0K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 227,112 | $476.9K | 0.00% | −51,215−18.4% | Reduced |
| Capital World Investors | 250,000 | $525.0K | 0.00% | 00.0% | Unchanged |
| Capital International Investors | 448,804 | $942.5K | 0.00% | 00.0% | Unchanged |
| Baillie Gifford & Co | 599,896 | $1.26M | 0.00% | −188,941−24.0% | Reduced |
| Millennium Management LLC | 679,966 | $1.43M | 0.00% | +106,125+18.5% | Added |
| Principal Financial Group Inc | 1,334,050 | $2.80M | 0.00% | −9,417−0.7% | Reduced |
| Credit Suisse AG | 1,438,255 | $3.02M | 0.00% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 2,683,633 | $5.64M | 0.93% | 00.0% | Unchanged |
| State Street Corp | 0 | $0 | 0.00% | −262,368−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −210,659−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −169,802−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −108,744−100.0% | Sold out |
| Kettle Hill Capital Management, LLC | 0 | $0 | 0.00% | −104,596−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −85,864−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −74,532−100.0% | Sold out |
| WS Management LLLP | 0 | $0 | 0.00% | −50,907−100.0% | Sold out |
| Baird Financial Group, Inc. | 0 | $0 | 0.00% | −32,640−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −18,352−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −14,900−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −13,303−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −10,977−100.0% | Sold out |
| Princeton Capital Management LLC | 0 | $0 | 0.00% | −10,594−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −168−100.0% | Sold out |